In vitro blockade of Gal3 using antibodies [78], interfering RNA [76,79], or chemical inhibitors [80,81] impairs proliferation, migration, invasion, and anchorage-independent growth of several pancreatic cancer cell lines, underscoring the contribution of Gal3 to tumor progression (Table 1). The gene discussed is LGALS3; the disease is pancreatic neoplasm.